Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Indivior Pharmaceuticals Inc. Common Stock (INDV) vs Shopify Inc. (SHOP) Price & Performance

Indivior Pharmaceuticals Inc. Common StockTrade
Shopify Inc.Trade

Price performance (Past 24H)

Key statistics

Indivior Pharmaceuticals Inc. Common Stock vs Shopify Inc. — how do they compare? Indivior Pharmaceuticals Inc. Common Stock trades at $34.01 (market cap $4.18B), while Shopify Inc. trades at $169.41 (market cap $227.12B). The key difference: Shopify Inc. is far larger — about 54.3× Indivior Pharmaceuticals Inc. Common Stock's market cap, and Shopify Inc. is trading nearer its 52-week high, Indivior Pharmaceuticals Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Indivior Pharmaceuticals Inc. Common Stock for 0 Days and Shopify Inc. for 78 Days on average.

INDVSHOP
Market Cap
$4.18B$227.12B
Volume
1,819,7466,965,160
Sector
HealthTechnology
52-Week High
$41.83$179.22
52-Week Low
$24.09$95.40
Typical Hold Time
0 Days78 Days
Enterprise Value
$4.47B$222.35B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Indivior Pharmaceuticals Inc. Common Stock

No Aura AI signal available yet.

Shopify Inc.

SHOP trades at $172.50, down 3.75% today but maintains a bullish technical outlook with strong moving average support. The company shows robust revenue growth from $5.6B in 2022 to $11.6B in 2025, though valuation ratios remain elevated with a P/E of 119.27. Recent news highlights Shopify's AI innovations including Canvas site-building tool and open AI agent checkout, positioning it favorably against competitors.

Shopify's outlook remains positive with 67% analyst buy ratings and $172.47 consensus target. Key opportunities include AI-driven commerce expansion and merchant solutions growth accelerating to 37%. Risks include high valuation multiples and competitive pressure from Amazon's opposing AI strategy. The stock offers growth potential but requires monitoring of earnings sustainability.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

INDV
100% Buy0% Sell
Avg holding period · 0 Days
SHOP
0% Buy100% Sell
Avg holding period · 78 Days

Top news

Latest headlines on both assets

About Indivior Pharmaceuticals Inc. Common Stock

Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.

Read more on INDV →

About Shopify Inc.

Shopify Inc. provides a cloud-based commerce platform. The Company offers a platform for merchants to create an omni-channel experience that helps showcase the merchant's brand.

Read more on SHOP →